Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.36.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.41 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.71ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.142ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.166ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.11 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.315ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.204ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.50ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.170ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.232ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.84ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.76ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.301ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.269ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.165ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
V.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.149ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.413ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.107ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.575.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.620ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
P.1.16 (Gamma)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.34.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.4.2.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used